Coreceptors CD28 and cytotoxic T lymphocyte antigen (CTLA)-4 have opposing effects on TcR/CD3 activation of T cells. While CD28 enhances and CTLA-4 inhibits activation, the underlying molecular basis of these effects has yet to be established. In this context, ganglioside and cholesterol enriched membrane microdomains (rafts, GEMs) serve as centers of signaling in T cells. Although CD28 can promote TcR/raft colocalization, evidence is lacking on whether the surface expression of membrane rafts can be targeted by CTLA-4 in its modulation of T cell responses. In this study, we demonstrate that both CD28 and CTLA-4 profoundly alter the surface expression of membrane rafts during T cell activation. While CD28 increased expression and the number of peripheral T cells induced to express surface rafts in response to TcR ligation, CTLA-4 potently inhibited both TcR and TcR × CD28 induced raft expression on the surface of T cells. Consistent with this, CD28 increased the presence of the linker of activated T cells (LAT) in purified membrane rafts, while CTLA-4 coligation effectively blocked this increase. Further, the reversal of the CTLA-4 block with CD3/CD28 ligation was accompanied by an increase in surface raft expression and associated LAT. Our observations demonstrate for the first time that CTLA-4 targets the release of rafts to the surface of T cells, and provides a mechanism for the opposing effects of CD28 and CTLA-4 on costimulation.
Skip Nav Destination
Article navigation
3 December 2001
Brief Definitive Report|
December 03 2001
Cytotoxic T Lymphocyte Antigen 4 and CD28 Modulate Cell Surface Raft Expression in Their Regulation of T Cell Function
Margarita Martin,
Margarita Martin
1Department of Cancer Immunology and AIDS, Dana-Farber Cancer Institute
2Department of Pathology, Harvard Medical School, Boston, MA 02115
Search for other works by this author on:
Helga Schneider,
Helga Schneider
1Department of Cancer Immunology and AIDS, Dana-Farber Cancer Institute
3Department of Medicine, Harvard Medical School, Boston, MA 02115
4Department of Haematology, Faculty of Medicine, Imperial College of Science, Technology and Medicine, Hammersmith Hospital, London W12 ONN, United Kingdom
Search for other works by this author on:
Abdallah Azouz,
Abdallah Azouz
1Department of Cancer Immunology and AIDS, Dana-Farber Cancer Institute
3Department of Medicine, Harvard Medical School, Boston, MA 02115
Search for other works by this author on:
Christopher E. Rudd
Christopher E. Rudd
1Department of Cancer Immunology and AIDS, Dana-Farber Cancer Institute
2Department of Pathology, Harvard Medical School, Boston, MA 02115
4Department of Haematology, Faculty of Medicine, Imperial College of Science, Technology and Medicine, Hammersmith Hospital, London W12 ONN, United Kingdom
Search for other works by this author on:
Margarita Martin
1Department of Cancer Immunology and AIDS, Dana-Farber Cancer Institute
2Department of Pathology, Harvard Medical School, Boston, MA 02115
Helga Schneider
1Department of Cancer Immunology and AIDS, Dana-Farber Cancer Institute
3Department of Medicine, Harvard Medical School, Boston, MA 02115
4Department of Haematology, Faculty of Medicine, Imperial College of Science, Technology and Medicine, Hammersmith Hospital, London W12 ONN, United Kingdom
Abdallah Azouz
1Department of Cancer Immunology and AIDS, Dana-Farber Cancer Institute
3Department of Medicine, Harvard Medical School, Boston, MA 02115
Christopher E. Rudd
1Department of Cancer Immunology and AIDS, Dana-Farber Cancer Institute
2Department of Pathology, Harvard Medical School, Boston, MA 02115
4Department of Haematology, Faculty of Medicine, Imperial College of Science, Technology and Medicine, Hammersmith Hospital, London W12 ONN, United Kingdom
Address correspondence to C.E. Rudd, Department of Haematology, Faculty of Medicine, Imperial College of Science, Technology and Medicine, Hammersmith Hospital, Du Cane Rd., London W12 ONN, UK. Phone: 020-8383-8421; Fax: 020-8383-8434; E-mail: [email protected]
M. Martin and H. Schneider contributed equally to this work.
Received:
June 19 2001
Revision Received:
September 04 2001
Accepted:
October 01 2001
Online ISSN: 1540-9538
Print ISSN: 0022-1007
The Rockefeller University Press
2001
J Exp Med (2001) 194 (11): 1675–1682.
Article history
Received:
June 19 2001
Revision Received:
September 04 2001
Accepted:
October 01 2001
Citation
Margarita Martin, Helga Schneider, Abdallah Azouz, Christopher E. Rudd; Cytotoxic T Lymphocyte Antigen 4 and CD28 Modulate Cell Surface Raft Expression in Their Regulation of T Cell Function . J Exp Med 3 December 2001; 194 (11): 1675–1682. doi: https://doi.org/10.1084/jem.194.11.1675
Download citation file:
Sign in
Don't already have an account? Register
Client Account
You could not be signed in. Please check your email address / username and password and try again.
Could not validate captcha. Please try again.
Sign in via your Institution
Sign in via your InstitutionSuggested Content
Email alerts
Advertisement